How urologists can help patients prevent stones
Here is what is recommended for fluid intake and dietary changes.
Prostate cancer functional and oncological outcomes vary among surgeons
The trend persists even after adjusting for surgical volume and experience.
Was this patient with stones properly informed of bladder mass?
Jury apportions fault among the plaintiff as well as the defendants.
Part B data reveal increased usage of denosumab and mitomycin
Leuprolide acetate remains the most commonly used androgen suppression drug.
High-TMB predicts immunotherapy response in bladder but not prostate cancer
“This study represents the most comprehensive analysis to date of tumor mutation burden as a biomarker for response to immune checkpoint blockade,” according to lead study author Daniel J. McGrail, PhD.
Mental disorder risk elevated in men with Peyronie’s disease
Men with Peyronie’s disease have an increased risk of being diagnosed with a substance use disorder, anxiety disorder, depression, and self-injurious behaviors.
Can CPT code 51798 be billed as part of a TURP?
Medical necessity must be documented on the chart in order to bill code.
Freehand transperineal prostate biopsy case series and review support widespread use
The technique is safer and more accurate than transrectal biopsy, an investigator says.
What is your clearest memory from the day you received your urology residency match?
“I remember being, I guess, relieved that I matched. It’s so competitive. It’s never a sure thing. You match somewhere; I remember relief with that," says 1 urologist.
Gomella details evolving treatment paradigm in NMIBC
Investigational agents on the horizon include Vicineum, nadofaragene firadenovec, and N-803 (Anktiva).
PSMA theranostic 177Lu-PSMA-617 more active, safer than cabazitaxel in mCRPC
PSA response rate was higher with the investigational radioligand therapy.
Researchers report positive preliminary experience with super pulse thulium fiber laser lithotripsy
North American urologists analyzing outcomes from their initial experience treating urolithiasis with the high-power super pulse thulium fiber laser (Soltive) are encouraged by the results.
Bipolar Androgen Therapy sensitizes CRPC to subsequent antiandrogen therapy
“The most important finding is that post-abiraterone, [bipolar androgen therapy] can markedly improve the magnitude and duration of response to enzalutamide,” the authors wrote.
Study compares outcomes with common surgeries for LUTS related to BPO
The retrospective study compared reintervention rates in the 4 standard surgical interventions for lower urinary tract symptoms due to benign prostatic obstruction.
Apalutamide survival benefit in mCSPC sustained in long-term follow-up
After adjusting for crossover using a preplanned sensitivity analysis, investigators for the pivotal phase 3 TITAN trial found a 48% reduction in the risk of death in patients treated with apalutamide plus ADT versus ADT alone.
Relapse rates not higher with RARC versus open radical cystectomy
Disease stage and adverse features were the main predictors of relapses and survival after robot-assisted radical cystectomy.
2 Clarke Drive Cranbury, NJ 08512